CIK: 0001232621
Total reported value
$2.0B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HRTX | Heron Therapeutics INC | Stock-Other | 42.49% | -0.15% | -0.13% | |
| 2 | LJPC | La Jolla Pharmaceutical Co | Stock-Other | 36.35% | — | — | |
| 3 | ✓ | Ignyta INC | Stock-Other | 17.50% | — | +19.91% | |
| 4 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 2.91% | — | — | |
| 5 | ✓ | Cyclacel Pharmaceuticals INC | Stock-Other | 0.75% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Ignyta INC | +5.2% | +19.91% | Add |
| 2 | BMRN | Biomarin Pharmaceutical INC | +0.1% | — | Unchanged |
| 3 | ✓ | Cyclacel Pharmaceuticals INC | 0% | — | Unchanged |
| 4 | LJPC | La Jolla Pharmaceutical Co | -0.8% | — | Unchanged |
| 5 | HRTX | Heron Therapeutics INC | -4.4% | -0.13% | Trim |